ENGN
naam in afwachting van profielverwerking
Momentum-inputs (vergelijkbare managers):
breedte van houders -15.4% ·
aandelenstroom +30.0% ·
netto nieuwe posities -18.2%
· formule
Geconcentreerde accumulatie: stijgende aandelen bij minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2026
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 22 | -4 | 8.16M | $14.12M | +4 | −8 |
| Q1 2026 | 26 | +4 | 5.29M | $36.02M | +6 | −2 |
| Q4 2025 | 22 | +2 | 7.05M | $63.63M | +3 | −1 |
| Q3 2025 | 8 | -1 | 3.24M | $22.15M | n/a | −1 |
| Q2 2025 | 7 | +2 | 2.63M | $9.57M | +3 | −1 |
| Q1 2025 | 5 | 0 | 3.20M | $14.35M | n/a | n/a |
| Q4 2024 | 5 | 0 | 3.41M | $22.70M | n/a | n/a |
| Q3 2024 | 5 | 0 | 3.74M | $24.69M | +1 | −1 |
| Q2 2024 | 5 | n/a | 4.75M | $44.79M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Ameriprise Financial Inc | 2.68M | Nieuw | $4.63M | 0.0% | New | 1 | SEC ↗ |
| 2 | Balyasny Asset Management L.P. | 1.01M | -12.3% | $1.74M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Millennium Management ✦ | 966.63K | +0.7% | $1.67M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 4 | Renaissance Technologies ✦ | 829.70K | +431.5% | $1.44M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 717.69K | +366.2% | $1.24M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | UBS Group AG | 509.09K | +3810.9% | $880,721 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Jane Street Group, Llc | 382.46K | +145.2% | $661,654 | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 8 | Barclays Plc | 282.51K | +82506.7% | $488,751 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Squarepoint Ops LLC | 215.38K | +340.5% | $372,609 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Qube Research & Technologies Ltd | 200.19K | Nieuw | $346,324 | 0.0% | New | 1 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 164.57K | +3.5% | $284,706 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Dimensional Fund Advisors Lp | 38.29K | +3.9% | $66,243 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 13 | Morgan Stanley ✦ | 33.09K | -61.8% | $57,239 | 0.0% | ▼ Trim | 4 | SEC ↗ ×4 |
| 14 | Bnp Paribas Financial Markets | 25.42K | -61.1% | $43,975 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Susquehanna International Group, Llp | 24.47K | Nieuw | $42,333 | 0.0% | New | 1 | SEC ↗ |
| 16 | Raymond James Financial Inc | 21.36K | +1.7% | $36,946 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Sei Investments Co | 18.50K | -69.2% | $32,012 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Hrt Financial Lp | 16.83K | -47.4% | $29,000 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 13.99K | -91.9% | $24,206 | 0.0% | ▼ Trim | 9 | SEC ↗ |
| 20 | Royal Bank Of Canada | 11.32K | +7.4% | $20,000 | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 21 | Wells Fargo & Company/Mn | 6.84K | -45.1% | $11,833 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Simplex Trading, Llc | 399 | Nieuw | $690 | 0.0% | New | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Ameriprise Financial Inc | $4.63M | 0.0% |
| Qube Research & Technologies… | $346,324 | 0.0% |
| Susquehanna International… | $42,333 | 0.0% |
| Simplex Trading, Llc | $690 | 0.0% |
Verlaten
| Franklin Resources Inc | $8.96M | was 0.0% |
| Marshall Wace | $2.34M | was 0.0% |
| Fidelity (FMR) | $1.58M | was 0.0% |
| Geode Capital Management | $264,242 | was 0.0% |
| American Century Companies Inc | $223,783 | was 0.0% |
| Northern Trust Corp | $204,879 | was 0.0% |
| JPMorgan Chase | $12,218 | was 0.0% |
| Citigroup Inc | $674 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 2 houders, 343.96K aandelen, $2.34M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Officer, Director · Interim Chief Medical… · 5.10K aand @ 1.97 · $10,051
Open-market verkopen (S)
Geen open-market insider-verkopen in ons dekkingsvenster.
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie